Array BioPharma Inc. just filed a General Statement of acquisition of beneficial ownership


The following excerpt is from the company's filing:

Item 5.
Ownership of Five Percent or Less of a Class.

Not Applicable.
Item 6.
Ownership of More than Five Percent on Behalf of Another Person.
Pursuant to the operating agreement of BVLLC, Partners is authorized, among other things, to invest the contributed capital of Samana Capital, L.P., the majority member of BVLLC, in the shares of Common Stock and other securities of the Issuer and to vote, exercise or convert and dispose of each security, and is entitled to receive fees based on assets under management and, subject to certain exceptions, allocations based on realized and unrealized gains on such assets.
Partners, BVF Inc. and Mr. Lampert share voting and dispositive power over the shares of Common Stock beneficially owned by BVF, BVF2, BVLLC, ILL10 and MSI.
Item 7.
Identification and Classification of the Subsidiary That Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Item 8.
Identification and Classification of Members of the Group.
See Exhibit 99.1.
Item 9.
Notice of Dissolution of Group.
Item 10.
Certifications.
By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
13

CUSIP NO. 04269X105
SIGNATURE
After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here. Array BioPharma Inc. next reports earnings on August 04, 2014.

To receive a free e-mail notification whenever Array BioPharma Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

Array BioPharma Inc. Just Filed Its Quarterly Report: Basis of Presentatio... - Nov. 5, 2014
Array Biopharma Reports Financial Results For The - Nov. 4, 2014
Array BioPharma: Entry Into A Material Definitive Agreement - Nov. 4, 2014
Array BioPharma Inc. director was just granted 25,000 options - Oct. 31, 2014
Array BioPharma Inc. director was just granted 25,000 options - Oct. 31, 2014

   Auto Refresh

Feedback